Improved survival and MRD remission with blinatumomab vs. chemotherapy in children with first high-risk relapse B-ALL

Franco Locatelli, Gerhard Zugmaier, Carmelo Rizzari, Joan D Morris, Bernd Gruhn, Thomas Klingebiel, Rosanna Parasole, Christin Linderkamp, Christian Flotho, Arnaud Petit, Concetta Micalizzi, Yi Zeng, Rajendra Desai, William N Kormany, Cornelia Eckert, Anja Möricke, Mary Sartor, Ondrej Hrusak, Christina Peters, Vaskar SahaLuciana Vinti, Arend von Stackelberg

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)222-225
Number of pages4
Issue number1
Publication statusPublished - Jan 2023


  • Humans
  • Child
  • Neoplasm Recurrence, Local/drug therapy
  • Antibodies, Bispecific/therapeutic use
  • Disease-Free Survival
  • Recurrence
  • Neoplasm, Residual/drug therapy
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/drug therapy
  • Remission Induction

Cite this